Food & Drug Administration (FDA) guidance is just now addressing the challenges of manufacturing cell and gene therapy (CGT) products with a proposed draft guidance, Manufacturing Changes and ...
The values of trademark licences and ownership are surprisingly difficult to compare, even though they are based on the same asset. A survey of both kinds of transaction examines the reasons for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback